Los Angeles, CA April 24, 2018 — Objective Capital Partners, a leading middle market investment banking firm, is pleased to announce that it served as the exclusive financial advisor to StudyKIK LLC, a rapidly-growing healthcare IT company, on its acquisition by Kinderhook Industries LLC.
“Matt and his team have done a remarkable job in creating a leading patient recruiting platform which is having an enormous impact by making it dramatically more efficient for clinical trial companies to find and engage the high-fit trial volunteers they need to bring new and innovative treatments to market,” said Channing Hamlet, Managing Director of Objective Capital Partners. “We are privileged to have had this opportunity to help StudyKIK and couldn’t be more excited about the future of the company.”
“We are thrilled to have the opportunity to partner with Kinderhook,” said Matt Miller, Co-Founder of StudyKIK. “When we set out to find the right partner to help fulfill our vision for StudyKIK, we were focused on identifying a firm that could provide us with the strategic resources, technological prowess and business connections we need to rapidly grow our business. Kinderhook’s background with building companies like the site network Radiant Research showed us they understand this clinical trial industry and how StudyKIK can leapfrog with the innovative Kinderhook team.”
Headquartered in Costa Mesa, CA, StudyKIK utilizes social media to provide disruptive patient recruiting solutions for clinical trials. The Company is a first mover in leveraging social media community groups in the patient recruitment space, using these methods to address the recruitment and retention of patients in the $40+ billion clinical trial industry that has historically relied on traditional advertising mediums. StudyKIK serves over 1,400 research sites with a growing database of over 2,000,000 active patients from its extensive social media communities across Facebook, Instagram, Snapchat, Twitter, Pinterest, and more.
About Objective Capital Partners
Objective Capital Partners provides M&A, capital raising, valuation, and strategic advisory services to entrepreneurs and middle-market companies in five industry sectors of focus: Technology, Healthcare, Consumer, Life Sciences, and Business Services. Headquartered in Southern California since 2006, the executive team have collectively advised in more than 500 successful transactions and bring a unique combination of investment banking experience and industry expertise that enables Objective Capital Partners to provide enterprise caliber investment banking services to middle market companies. For more information please visit: www.objectiveibv.com.
StudyKIK utilizes social media to provide disruptive patient recruiting solutions for clinical trial sites, clinical research organizations, and pharmaceutical companies. The Company is a first mover in the patient recruitment space, using social media advertising to address recruiting and retention of patients in the $40bn+ clinical trial industry that has historically relied on traditional advertising mediums such as print and radio. StudyKIK serves over 1,400 research sites with a growing database of over 2,000,000 patients from its extensive social media communities across Facebook, Instagram, Snapchat, Twitter, and Pinterest. For more information visit www.studykik.com.
About Kinderhook Industries
Kinderhook Industries, LLC is a private investment firm that manages over $2.0 billion of committed capital. They have made in excess of 150 investments and follow-on acquisitions since inception. Kinderhook’s investment philosophy is predicated on matching unique, growth-oriented investment opportunities with exceptional financial expertise and our proprietary network of operating partners. Their focus is on middle market businesses with defensible niche market positioning in the healthcare services, environmental / business services and automotive / light manufacturing sectors. Kinderhook has a track record of successfully and consistently building industry leaders. In addition, Kinderhook is a licensed Small Business Investment Company (SBIC) with the U.S. Small Business Administration. For more information please visit: www.kinderhook.com.
Disclosure This news release is for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC make no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. All information contained herein is preliminary, limited and subject to completion, correction or amendment. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person. Securities and investment banking services are offered through BA Securities, LLC Member FINRA, SIPC. Principals of Objective Capital are Registered Representatives of BA Securities. Objective Capital Partners and BA Securities are separate and unaffiliated entities.